RWJ-67657 (Standard) is the analytical standard of RWJ-67657. This product is intended for research and analytical applications. RWJ-67657 (JNJ 3026582) is an orally active and selective p38alpha and p38beta MAPK inhibitor with IC50s of 1 and 11 µM, respectively. RWJ-67657 displays no activity at p38gamma and p38delta, and exhibits cardio protective effect. Anti-inflammatory and anti-tumor activity[1].
Molekulargewicht:
425.50
CAS Nummer:
[215303-72-3]
Formel:
C27H24FN3O
Target-Kategorie:
p38 MAPK,Reference Standards
Anwendungsbeschreibung:
MCE Product type: Reference Standards
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten